Access 2.8M+ Filings Sign Up Free
Strategic Partners A/S Logo

Strategic Partners A/S | STRAP - Profile, Filings, Stock Info & Investor Relations Data

Strategic Partners A/S | STRAP
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Denmark
Founded
2009
Strategic Partners A/S (STRAP)

Company Profile

Website
Investor Relations

About Strategic Partners A/S

Orphazyme was founded in Denmark in 2009 on a scientific discovery about the role of heat shock proteins (HSPs), which was described in a well-cited article published in the journal Nature.

We translated this scientific discovery into late-stage clinical trials of our investigational drug candidate, arimoclomol, with the aim of developing new treatment options for people with neurodegenerative diseases, such as Niemann-Pick disease type-C (NPC).

In May 2022, substantially all of Orphazyme’s assets and business activities, including those relating to the development and approval of arimoclomol, were sold to KemPharm Denmark A/S, a wholly owned subsidiary of KemPharm, Inc.

Headquarters

Lyskær 8 A st. tv.
2730, Herlev
Denmark

Strategic Partners A/S (STRAP)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Strategic Partners A/S (STRAP)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Strategic Partners A/S (STRAP)
Stock & Investor Information

ISINs

DK0062502894
US6873051022

LEI

54930025OZD2GGSQ7L42

Stock Exchange Listings

Nasdaq Copenhagen

Industry Classification

Sector
Health Care
Industry
Biotechnology